|
業務類別
|
Biotechnology |
|
業務概覽
|
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases. |
| 公司地址
| 6005 Hidden Valley Road, Suite 110, Carlsbad, CA, USA, 92011 |
| 電話號碼
| +1 858 293-4900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.designtx.com |
| 員工數量
| 54 |
| Dr. Pratik Shah, PhD |
Chairperson of the Board, President, Chief Executive Officer and Principal Financial Officer |
美元 395.00K |
24/04/2025 |
| Ms. Julie Burgess |
Chief Accounting Officer |
-- |
10/03/2025 |
| Mr. Chris Storgard, M.D. |
Chief Medical Officer |
-- |
24/04/2025 |
| Dr. Sean Jeffries, PhD |
Chief Operating Officer |
美元 432.65K |
24/04/2025 |
|
|
| Dr. Pratik Shah, PhD |
Chairperson of the Board, President, Chief Executive Officer and Principal Financial Officer |
24/04/2025 |
| Dr. Heather Berger, PhD |
Independent Director |
24/04/2025 |
| Mr. John P. Schmid |
Independent Director |
24/04/2025 |
| Mr. Justin David Gover |
Director |
10/09/2025 |
| Dr. Rodney W. Lappe, PhD |
Independent Director |
24/04/2025 |
| Dr. Simeon J. George, M.B.A.,M.D. |
Lead Independent Director |
24/04/2025 |
|
|
|
|
